Trimeris, Inc. : Premium Company Profile

Introduction

Trimeris is a biopharmaceutical company having the credit of successfully developing first fusion inhibitor: FUZEON, representing the first new class of anti-HIV treatments in seven years. As a part of its strategic initiatives in 2008, the company plans to: focus tightly on maximizing FUZEON’s profitability by utilizing the resources and strengths of its collaborator, Roche.

Scope

Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Trimeris is primarily engaged in the discovery, development and commercialization of a class of antiviral drug treatments called fusion inhibitors. FUZEON, indicated for treating HIV/AIDS, is the only marketed product of Trimeris developed in collaboration with Roche.The company’s lead product candidate, TRI-1144 is in preclinical research. Trimeris derives its revenues as royalties from Roche based on total net sales of FUZEON outside the US and Canada and collaboration income on FUZEON sales in the US and Canada. The company develops products utilizing its own or combined research efforts of its collaborators. Trimeris did not record any revenues during 2002-2004. The company’s total revenues increased from $19 million in 2005 to $37 million in 2006. The company’s biggest contributor to revenue growth during 2005-2006 was collaboration income on FUZEON sales in the US and Canada.

Reasons to Purchase

• Access all the important information and analysis on the company in a single report
• Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
• Gain access to company’s adjusted five year financial data along with key ratios and market capitalization.

TABLE OF CONTENTS
Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 8
Company Financials 9
Stock Market Performance 9
P&L 12
Balance Sheet 14
Cash Flow 14
Business Segment Performance 15
Products & Services 17
Marketed Products 17
Pipeline Products 18
AC Forecast Product Sales 19
Competitors and Strategic Business Relationships 21
Key Competitors 21
Key Suppliers 22
Key Clients 22
Shareholding Structure 23
Strategy 24
Company View 24
Corporate Strategy 27
SWOT Analysis 29
Overview 29
Strengths 30
Weaknesses 31
Opportunities 32
Threats 34
Value Chain Analysis 35
Discovery and Product Development 36
Scorecard 37
Overview 37
Scorecard Analysis 38
Key Employees 39
List of Key Employees 39
Key Employee Biographies 40
Financial and Operational overview 44
Financial and Operational Overview 44
APPENDIX 47
Ask the analyst 47
Datamonitor consulting 47
Disclaimer 47


TABLE OF FIGURES
Figure 1: Trimeris - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
Figure 2: Trimeris - Key Strategic Revenues, 2002-2006 ($ Mn) 16
Figure 3: Trimeris - Key Strategic Revenues, 2006-2010 ($ Mn) 20


TABLE OF TABLES
Table 1: Trimeris - Key Facts 6
Table 2: Trimeris - Year-End Share Price and Market Capitalization, 2002-2006 ($) 9
Table 3: Trimeris - Key Events Impacting Share Price Performance 10
Table 4: Trimeris - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 12
Table 5: Trimeris - Balance Sheet, 2002-2006 ($ Mn) 14
Table 6: Trimeris - Cash Flow, 2002-2006 ($ Mn) 14
Table 7: Trimeris - Revenue Breakdown by Division, 2002-2006 ($ Mn) 15
Table 8: Trimeris - Marketed Products 17
Table 9: Trimeris - In-house Pipeline Products 18
Table 10: Trimeris - Forecast Sales, 2006-2010 ($ Mn) 19
Table 11: Trimeris - Key Competitors 21
Table 12: Trimeris - Key Suppliers 22
Table 13: Trimeris - Key Clients 22
Table 14: Trimeris - Key Shareholders 23
Table 15: Trimeris - SWOT Analysis Summary 29
Table 16: Trimeris – Value Chain Analysis 35
Table 17: Trimeris - Scorecard 37
Table 18: Trimeris - Key Employees 39
Table 19: Trimeris – Financial and Operational Overview 45